These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7552367)

  • 1. NBQX, a selective antagonist of the AMPA receptor, affects neither field potentials nor long-term potentiation in vivo.
    Sato K; Morimoto K; Yamada N; Kuroda S; Hayabara T
    Brain Res; 1995 Jun; 683(2):279-82. PubMed ID: 7552367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPA receptor antagonists, GYKI 52466 and NBQX, do not block the induction of long-term potentiation at therapeutically relevant concentrations.
    Kapus G; Székely JI; Durand J; Ruiz A; Tarnawa I
    Brain Res Bull; 2000 Aug; 52(6):511-7. PubMed ID: 10974490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat.
    Kodama M; Yamada N; Sato K; Kitamura Y; Koyama F; Sato T; Morimoto K; Kuroda S
    Eur J Pharmacol; 1999 Jun; 374(1):11-9. PubMed ID: 10422635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking the trigeminal EPSP in rat abducens motoneurons in vivo with the AMPA antagonists NBQX and GYKI 53655.
    Ruiz A; Durand J
    Brain Res Bull; 2000 May; 52(2):99-107. PubMed ID: 10808079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine.
    Li Y; Vartanian AJ; White FJ; Xue CJ; Wolf ME
    Psychopharmacology (Berl); 1997 Dec; 134(3):266-76. PubMed ID: 9438676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
    Hu P; Diemer NH; Bruhn T; Johansen FF
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
    Swedberg MD; Jacobsen P; Honoré T
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution.
    Randle JC; Guet T; Cordi A; Lepagnol JM
    Eur J Pharmacol; 1992 May; 215(2-3):237-44. PubMed ID: 1382998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
    Wrathall JR; Teng YD; Marriott R
    Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors.
    Mead AN; Stephens DN
    J Pharmacol Exp Ther; 1999 Jul; 290(1):9-15. PubMed ID: 10381753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists.
    Yamada KA; Turetsky DM
    Br J Pharmacol; 1996 Apr; 117(8):1663-72. PubMed ID: 8732274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists.
    Maj J; Rogóz Z; Skuza G; Jaros T
    Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The AMPA receptor antagonist NBQX exerts antidystonic effects in an animal model of idiopathic dystonia.
    Richter A; Löscher W; Löschmann PA
    Eur J Pharmacol; 1993 Feb; 231(2):287-91. PubMed ID: 8384114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A crucial role of the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype of glutamate receptors in piriform and perirhinal cortex for the initiation and propagation of limbic motor seizures.
    Tortorella A; Halonen T; Sahibzada N; Gale K
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1401-5. PubMed ID: 9067329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NBQX, an improved non-NMDA antagonist studied in retinal ganglion cells.
    Yu W; Miller RF
    Brain Res; 1995 Sep; 692(1-2):190-4. PubMed ID: 8548303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the non-NMDA receptor antagonist, 2,3-dihydro-6-nitro-7-sulfamoylbenzo(f)quinoxaline, on local cerebral glucose uptake in the limbic forebrain.
    Suzdak PD; Sheardown MJ
    J Neurochem; 1993 Oct; 61(4):1577-80. PubMed ID: 8397300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy.
    Namba T; Morimoto K; Sato K; Yamada N; Kuroda S
    Brain Res; 1994 Feb; 638(1-2):36-44. PubMed ID: 8199874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of NBQX on hypoxia-induced neuronal damage in rat hippocampus.
    Matsuoka Y; Kitamura Y; Tsukahara T; Terai K; Tooyama I; Kimura H; Taniguchi T
    Neuroreport; 1995 Nov; 6(16):2205-8. PubMed ID: 8595203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.